Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas.

Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T.

Virchows Arch. 2008 Apr;452(4):377-82. doi: 10.1007/s00428-008-0597-6. Epub 2008 Feb 26.

PMID:
18299890
2.

Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men.

Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T.

Pathol Int. 2008 Aug;58(8):477-82. doi: 10.1111/j.1440-1827.2008.02259.x.

PMID:
18705766
3.

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.

Lung Cancer. 2007 Oct;58(1):131-8. Epub 2007 Jul 2.

PMID:
17606310
4.

Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach.

Schildhaus HU, Kröckel I, Lippert H, Malfertheiner P, Roessner A, Schneider-Stock R.

Int J Oncol. 2005 Jun;26(6):1493-500.

PMID:
15870861
5.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
6.
7.

[Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].

Shi HR, Wu QH, Suo ZH, Nesland JM.

Ai Zheng. 2005 Jan;24(1):7-11. Chinese.

PMID:
15642192
8.

Patterns of gene promoter methylation in squamous cell cancer of the head and neck.

Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT.

Oncogene. 2002 Jun 20;21(27):4231-6.

9.

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.

Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.

Carcinogenesis. 2004 Nov;25(11):2165-71. Epub 2004 Jul 1.

PMID:
15231689
10.

DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.

Guo XQ, Wang SJ, Zhang LW, Wang XL, Zhang JH, Guo W.

J Exp Clin Cancer Res. 2007 Dec;26(4):587-94.

PMID:
18365557
12.

Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.

Goldberg M, Rummelt C, Laerm A, Helmbold P, Holbach LM, Ballhausen WG.

Br J Dermatol. 2006 Dec;155(6):1154-8.

PMID:
17107382
13.

Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.

Foja S, Goldberg M, Schagdarsurengin U, Dammann R, Tannapfel A, Ballhausen WG.

Liver Int. 2005 Dec;25(6):1202-8.

PMID:
16343073
14.

Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.

Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W.

Oral Oncol. 2011 Feb;47(2):104-7. doi: 10.1016/j.oraloncology.2010.11.006. Epub 2010 Dec 13.

PMID:
21147548
15.

Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.

Neyaz MK, Kumar RS, Hussain S, Naqvi SH, Kohaar I, Thakur N, Kashyap V, Das BC, Husain SA, Bharadwaj M.

Biomarkers. 2008 Sep;13(6):597-606. doi: 10.1080/13547500802078859.

PMID:
18608185
16.

Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.

Hu SL, Kong XY, Cheng ZD, Sun YB, Shen G, Xu WP, Wu L, Xu XC, Jiang XD, Huang DB.

Tumori. 2010 Sep-Oct;96(5):726-33.

17.

Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.

Tzao C, Sun GH, Tung HJ, Hsu HS, Hsu WH, Wang YC, Cheng YL, Lee SC.

Ann Thorac Surg. 2006 Aug;82(2):396-401; discussion 401. Erratum in: Ann Thorac Surg. 2006 Dec;82(6):2342.

PMID:
16863736
18.

Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T.

Cancer Sci. 2003 Jul;94(7):589-92.

19.

Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.

Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D.

Mol Cancer Res. 2006 Feb;4(2):93-9.

20.

Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation.

Hussain A, Gutiérrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K.

Genes Chromosomes Cancer. 2004 Dec;41(4):321-9.

PMID:
15384174

Supplemental Content

Support Center